|1.||Tanaka, Kazuo: 1 article (08/2012)|
|2.||Chujo, Moeko: 1 article (08/2012)|
|3.||Minehara, Hiroki: 1 article (08/2012)|
|4.||Naka, Kensuke: 1 article (08/2012)|
|5.||Nagao, Masaya: 1 article (08/2012)|
|6.||Narita, Asako: 1 article (08/2012)|
|7.||Chujo, Yoshiki: 1 article (08/2012)|
|8.||Liu, Xing-Ping: 1 article (02/2003)|
|9.||Narla, Rama Krishna: 1 article (02/2003)|
|10.||Uckun, Fatih M: 1 article (02/2003)|
10/31/1919 - "III. THE THERAPEUTIC ACTION OF N-PHENYLGLYCINEAMIDE-p-ARSONIC ACID IN EXPERIMENTAL TRYPANOSOMIASIS OF RABBITS."
10/31/1919 - "N-PhenyIglycineamide-p-arsonic acid is an agent of marked therapeutic action in the treatment of experimental trypanosomiasis of mice, rats, and guinea pigs. "
10/31/1919 - "II. THE THERAPEUTIC ACTION OF N-PHENYLGLYCINEAMIDE-p-ARSONIC ACID IN EXPERIMENTAL TRYPANOSOMIASIS OF MICE, RATS, AND GUINEA PIGS."
10/31/1919 - "The therapeutic activity in trypanosomiasis of mice, rats, and guinea pigs as evidenced by the relative speed and sharpness of action, together with the curative ratio as expressed in fractions of the minimum lethal dose, and the absence of organic injury or functional disturbance following therapeutic doses are significant and characteristic features of the amide of N-phenylglycine-p-arsonic acid."
11/30/1921 - "STUDIES ON THE TREATMENT OF HUMAN TRYPANOSOMIASIS WITH TRYPARSAMIDE (THE SODIUM SALT OF N-PHENYLGLYCINEAMIDE-p-ARSONIC ACID)."
01/01/1990 - "Allergic inflammation was induced by injecting an antigen solution into an air pouch made on the dorsum of immunized rats with the antigen azobenzene-arsonate-conjugated acetyl bovine serum albumin. "
01/01/1983 - "Chemotactic activity at the site of an allergic air-pouch inflammation induced with azobenzene-arsonate-conjugated acetyl bovine serum albumin as an antigen was studied and a close correlation of the chemotactic activity with the intensity of leukocyte migration was demonstrated. "
01/01/1987 - "The recurrence of allergic inflammation, as examined by exudate accumulation, infiltration of polymorphonuclear leukocytes into the exudate, edema formation, vascular permeability and prostaglandin E2 levels in the exudate, was induced by injecting the antigen, azobenzene arsonate-conjugated acetyl bovine serum albumin, into the capsule of the proliferative granulation tissue which had been formed by the first-time antigenic challenge injection into an air pouch in the dorsum of the sensitized rat. "
10/31/1919 - "To summarize the results obtained from these experiments, one may say that N-phenylglycineamide-p-arsonic acid is capable of exercising a very definite effect upon the course of infections produced by spirochetes of the recurrens group and by Treponema pallidum. "
01/31/1921 - "THERAPEUTIC ACTION OF N-PHENYLGLYCINEAMIDE-p-ARSONIC ACID (TRYPARSAMIDE) UPON EXPERIMENTAL INFECTIONS OF TRYPANOSOMA RHODESIENSE."
10/31/1919 - "The therapeutic results with the amide of N-phenylglycine-p-arsonic acid were obtained in rabbits which showed well marked clinical signs of a definitely established disease, and in many instances the infection was extremely advanced and of prolonged duration. "
|5.||Delayed Hypersensitivity (Hypersensitivity, Type IV)
|1.||Copper Sulfate (Sulfate, Copper)
|6.||Bovine Serum Albumin